Sapphire Medical Clinics and Dendrite Clinical Systems have launched the UK Medical Cannabis Registry, an initiative that is designed to rapidly expand the evidence base for medical cannabis in the UK and decrease the cost of access for patients. The launch will collect and analyse clinical information on patients taking medical cannabis treatments for all recognised eligible conditions.
“I am very pleased to report that demand for the Dendrite Web-Registry platform has reached an all-time high” Dr Peter Walton, Managing Director of Dendrite Clinical System. “We’re receiving new orders for new national and international registries every few days now – for surgical registries, medical registries, rare disease registries, medical device registries and Coronavirus Registries (for a range of Community, National, International and Global Covid-19 Registries).”
Sapphire Medical Clinics and Dendrite Clinical Systems have established the UK’s first national UK’s first comprehensive medical cannabis patient registry - UK Medical Cannabis Registry. The UK Medical Cannabis Registry will be the first of its kind covering all conditions for which there is evidence of clinical efficacy of medical cannabis. The formation of the registry means that real world evidence, cited as a key barrier to wider patient prescriptions by NHS England, will now be available on request to the medical community for analysis.
The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), in conjunction with Dendrite Clinical Systems, is delighted to announce the release of the First UK National Flap Registry (UKNFR) Report. The UKNFR, which was launched in August 2015, collects information on all major free and pedicled flap operations carried out in the UK.
Dendrite Clinical Systems, the publisher of Bariatric News, has announced the publication of the Bariatric News Industry and Product Guide 2019 – a comprehensive A-Z guide to companies, products and services within the bariatric and metabolic specialty. 
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 39 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Real World Evidence
Dendrite Clinical Systems is a global leader in the area of clinical registries with an extensive experience in the field of Real World Evidence studies.
Real World Evidence goes beyond traditional controlled clinical trials. Pharmaceutical and medical device companies can use Real World Evidence data to inform stakeholders about a product's use, treatment patterns (standards of care), benefits and cost effectiveness to gain and defend market access, inform the design of products and trials and transform their relationships with clinicians from a supplier to a collaborator.
Large scale Real World Evidence data has not been available until recently – this is a major opportunity to demonstrate the value of your products. All of the major pharmaceutical companies have recently initiated Real World Evidence projects to inform product development and/or commercial decisions. Post market research has been the only growing area in the clinical research field in recent years. Indeed, if pharmaceutical and medical device companies do not take the initiative and lead the development of compelling real world cost-effectiveness arguments, regulatory agencies will create their own potentially unfavourable product narratives of which we have seen multiple examples already.
While there may be various sources of real world clinical information (such as Electronic Patient Record systems), implementation experience has proven that this information is mostly sporadic, incomplete and difficult to reconcile and analyse, particularly on a large scale. Clinical registries have proven to be the main source of scientifically robust large scale Real World Evidence to date.
Our customer dedication and delivery track record is impeccable. We would be delighted to work with you to help you design and support your Real World Evidence project.
Please contact us to discuss your Real World Evidence project:
Email: rwe@e-dendrite.com
Phone: +44 20 8949 8999 (Dr Alexey Brovko)
